The present application describes humanized anti-ErbB2 antibodies and methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies.

 
Web www.patentalert.com

< Mutated Lactococcus strain

> Methods of reducing the nicotine content of tobacco plants and tobacco plants obtained thereby

> Compositions and methods for the potentiation of immune responses against target antigens
~ 00521